Catalytic Ability Improvement of Phenylalanine Hydroxylase from Chromobacterium violaceum by N-Terminal Truncation and Proline Introduction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Phenylalanine hydroxylase from Chromobacterium violaceum (CvPAH) is a monomeric enzyme that converts phenylalanine to tyrosine. It shares high amino acid identity and similar structure with a subunit of human phenylalanine hydroxylase that is a tetramer, resulting in the latent application in medications. In this study, semirational design was applied to CvPAH to improve the catalytic ability based on molecular dynamics simulation analyses. Four Nterminal truncated variants and one single point variant were constructed and characterized. The D267P variant showed a 2.1-fold increased thermal stability compared to the wild type, but lower specific activity was noted compared with the wild type. The specific activity of all truncated variants was a greater than 25% increase compared to the wild type, and these variants showed similar or slightly decreased thermostability with the exception of the N-Δ9 variant. Notably, the N-Δ9 variant exhibited a 1.2-fold increased specific activity, a 1.3-fold increased thermostability and considerably increased catalytic activity under the neutral environment compared with the wild type. These properties of the N-Δ9 variant could advance medical and pharmaceutical applications of CvPAH. Our findings indicate that the N-terminus might modulate substrate binding, and are directives for further modification and functional research of PAH and other enzymes.
Abstract
Phenylalanine hydroxylase from Chromobacterium violaceum (CvPAH) is a monomeric enzyme that converts phenylalanine to tyrosine. It shares high amino acid identity and similar structure with a subunit of human phenylalanine hydroxylase that is a tetramer, resulting in the latent application in medications. In this study, semirational design was applied to CvPAH to improve the catalytic ability based on molecular dynamics simulation analyses. Four Nterminal truncated variants and one single point variant were constructed and characterized. The D267P variant showed a 2.1-fold increased thermal stability compared to the wild type, but lower specific activity was noted compared with the wild type. The specific activity of all truncated variants was a greater than 25% increase compared to the wild type, and these variants showed similar or slightly decreased thermostability with the exception of the N-Δ9 variant. Notably, the N-Δ9 variant exhibited a 1.2-fold increased specific activity, a 1.3-fold increased thermostability and considerably increased catalytic activity under the neutral environment compared with the wild type. These properties of the N-Δ9 variant could advance medical and pharmaceutical applications of CvPAH. Our findings indicate that the N-terminus might modulate substrate binding, and are directives for further modification and functional research of PAH and other enzymes.
참고문헌 (25)
- Abu-Omar MM, "Reaction mechanisms of mononuclear non-heme iron oxygenases", Chem. Rev, 105, pp.2227~2252 (2005)
- Flatmark T, "Structural insight into the aromatic amino acid hydroxylases and their disease-related mutant forms", Chem. Rev, 99, pp.2137~2160 (1999)
- Keil S, "Longterm follow-up and outcome of phenylketonuria patients on sapropterin : a retrospective study", Pediatrics, 131, pp.e1881~e1888 (2013)
- Levy HL, "Efficacy of sapropterin dihydrochloride(tetrahydrobiopterin, 6R-BH4)for reduction of phenylalanine concentration in patients with phenylketonuria : a phase III randomised placebo-controlled study", Lancet, 370, pp.504~510 (2007)
- Muntau AC, "Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria", N. Engl. J. Med, 347, pp.2122~2132 (2002)
- Zhu T, "The predictive value of genetic analyses in the diagnosis of tetrahydrobiopterin (BH4)-responsiveness in Chinese phenylalanine hydroxylase deficiency patients", Sci. Rep, 7, pp.6762~ (2017)
- Nakata H, "Phenylalanine hydroxylase from Chromobacterium violaceum, purification and characterization", J. Biol. Chem, 254, pp.1829~1833 (1979)
- Onishi A, "Cloning and expression of Chromobacterium violaceum phenylalanine hydroxylase in Escherichia coli and comparison of amino acid sequence with mammalian aromatic amino acid hydroxylases", J. Biol. Chem, 266, pp.18454~18459 (1991)
- Erlandsen H, "Structural comparison of bacterial and human iron-dependent phenylalanine hydroxylases : similar fold, different stability and reaction rates", J. Mol. Biol, 320, pp.645~661 (2002)
- Zoidakis J, "Effect of temperature, pH, and metals on the stability and activity of phenylalanine hydroxylase from Chromobacterium violaceum", J. Inorg. Biochem, 99, pp.771~775 (2005)
- Carr RT, "Mechanism of metal-independent hydroxylation by Chromobacterium violaceum phenylalanine hydroxylase", Biochemistry, 34, pp.7525~7532 (1995)
- Subedi BP, "Kinetic mechanism and intrinsic rate constants for the reaction of a bacterial phenylalanine hydroxylase", Biochemistry, 55, pp.6848~6857 (2016)
- Zoidakis J, "Role of the second coordination sphere residue tyrosine 179 in substrate affinity and catalytic activity of phenylalanine hydroxylase", J. Biol. Inorg. Chem, 9, pp.289~296 (2004)
- Ronau JA, "A conserved acidic residue in phenylalanine hydroxylase contributes to cofactor affinity and catalysis", Biochemistry, 53, pp.6834~6848 (2014)
- Kino K, "Enhancement of L-tryptophan 5-hydroxylation activity by structure-based modification of L-phenylalanine 4-hydroxylase from Chromobacterium violaceum", J. Biosci. Bioeng, 108, pp.184~189 (2009)
- Yew NS, "Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice", Mol. Genet. Metab, 109, pp.339~344 (2013)
- Phillips JC, "Scalable molecular dynamics with NAMD", J. Computat. Chem, 26, pp.1781~1802 (2005)
- MacKerell AD, "All-atom empirical potential for molecular modeling and dynamics studies of proteins", J. Phys. Chem. B, 102, pp.3586~3616 (1998)
- Yan M, "Molecular dynamics simulations of HIV-1 protease monomer : Assembly of N-terminus and C-terminus into bsheet in water solution", Proteins, 70, pp.731~738 (2008)
- Tian J, "Enhanced thermostability of methyl parathion hydrolase from Ochrobactrum sp, M231 by rational engineering of a glycine to proline mutation", FEBS J, 277, pp.4901~4908 (2010)
- Ge M, "The contribution of proline residues to protein stability is associated with isomerization equilibrium in both unfolded and folded states", Extremophiles, 13, pp.481~489 (2009)
- Kazlauskas R, "Engineering more stable proteins", Chem. Soc. Rev, 47, pp.9026~9045 (2018)
- Huang J, "Stabilization of an α", β-hydrolase by introducing proline residues : salicylic acid binding protein 2 from tobacco, 2015, pp.54, 4330~4341
- Singh MK, "Role of an N-terminal extension in stability and catalytic activity of a hyperthermostable α", β hydrolase fold esterase, 2017, pp.30, 559~570
- Stojanovski BM, "Murine erythroid 5-aminolevulinate synthase : Truncation of a disordered N-terminal extension is not detrimental for catalysis", Biochim. Biophys. Acta, 1864, pp.441~452 (2016)